SCHEMBL873936

SCHEMBL873936

CC(C)C1(CO)CCCCC1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14899026 1.00 DPP4 (0.30) DPP4
SCHEMBL345669 0.97
SCHEMBL14899025 0.92
SCHEMBL765795 0.86
SCHEMBL914671 0.82 TDP1 (0.30)
SCHEMBL4993231 0.80
SCHEMBL4492198 0.80 DPP4 (0.35) DPP4
SCHEMBL25663480 0.80 DPP4 (0.35) DPP4
SCHEMBL25515507 0.78 TDP1 (0.33)
SCHEMBL26998009 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999057233-A1 PERFUME COMPOSITION QUEST INTERNATIONAL B.V. (NL) 1999-11-11 WO claimed
US-11858931-B2 Amino acid compounds with unbranched linkers and methods of use PLIANT THERAPEUTICS, INC. (US) 2024-01-02 US disclosed
US-11447724-B2 Compositions that include siloxane compounds having pendant silyl ether moieties THE PROCTER & GAMBLE COMPANY (US) 2022-09-20 US disclosed
US-20200283706-A1 COMPOSITIONS THAT INCLUDE SILOXANE COMPOUNDS HAVING PENDANT SILYL ETHER MOIETIES THE PROCTER & GAMBLE COMPANY 2020-09-10 US disclosed
US-20190330239-A1 INDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 MERCK SHARP & DOHME CORP. (US) 2019-10-31 US disclosed
EP-2534281-B1 METHOD FOR PRODUCING 4-ISOPROPYLCYCLOHEXYLMETHANOL BASF SE (DE) 2019-01-09 EP disclosed
US-20180297922-A1 NOVEL OCTAHYDROINDENYL PROPANAL COMPOUNDS INT FLAVORS & FRAGRANCES INC (US) 2018-10-18 US disclosed
US-20180161329-A1 PYRIDO[3,4-D]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF TEIJIN PHARMA LIMITED (JP) 2018-06-14 US disclosed
US-20180161329-A1 PYRIDO[3,4-D]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF TEIJIN PHARMA LIMITED (JP) 2018-06-14 US disclosed
US-20170283431-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHOD OF THEIR USE JANSSEN PHARMACEUTICA NV (BE) 2017-10-05 US disclosed
US-20110207968-A1 PROCESS FOR PREPARING 4-ISOPROPYLCYCLOHEXYLMETHANOL BASF SE (DE) 2011-08-25 US disclosed
WO-2011098432-A2 METHOD FOR PRODUCING 4-ISOPROPYLCYCLOHEXYLMETHANOL BASF SE (DE) 2011-08-18 WO disclosed
WO-2011098432-A2 METHOD FOR PRODUCING 4-ISOPROPYLCYCLOHEXYLMETHANOL BASF SE (DE) 2011-08-18 WO disclosed
WO-2011082991-A2 CATALYST AND METHOD FOR HYDROGENATING AROMATES BASF SE (DE) 2011-07-14 WO disclosed
CN-1273127-C Perfume composition SHISEIDO CO LTD (JP) 2006-09-06 CN disclosed
CN-1538840-A Perfume composition ������������ʽ���� 2004-10-20 CN disclosed
US-5326748-A 3,3-dimethyl-5-(2,2,3-trimethyl-3-cyclohexen-1-yl)-4-penten-2-ol or its exocyclic unsaturated derivative; sandalwood FIRMENICH SA (CH) 1994-07-05 US disclosed
US-5114915-A Amber-woody odor; cosmetics FIRMENICH SA (CH) 1992-05-19 US disclosed
US-5087612-A Woody-amber odors FIRMENICH SA (CH) 1992-02-11 US disclosed
EP-0419860-A1 Oxygenated alicyclic compounds, their application as perfume constituents and method for making them FIRMENICH SA (CH) 1991-04-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180161329-A1 PYRIDO[3,4-D]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF CDK4, CDK6, CDK16 DPP4 396/4885
US-20180297922-A1 NOVEL OCTAHYDROINDENYL PROPANAL COMPOUNDS OR51E2, CUTA, POLR1C DPP4 2091/4885
US-20190330239-A1 INDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 DGAT2, DGAT1, MOGAT2 DPP4 231/4885
US-20170283431-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHOD OF THEIR USE ABL1, BTK, MYLK2 DPP4 4604/4885
US-20110207968-A1 PROCESS FOR PREPARING 4-ISOPROPYLCYCLOHEXYLMETHANOL CYP2E1, CYP3A4, DHPS DPP4 512/4885
US-11858931-B2 Amino acid compounds with unbranched linkers and methods of use ITGA2B, ITGB6, ITGB1 DPP4 4030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.